Antiviral prophylaxis vs placebo or no treatment
CMV infection · solid organ transplant recipients
Antiviral prophylaxis leads to lower CMV infection compared with placebo or no treatment (high certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.61 [0.48, 0.77]17 studies · 1786 participantsHigh